- Home
- VKTX vs ACLX Comparison
VKTX vs ACLX Comparison
Compare VKTX & ACLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VKTX
- ACLX
- Stock Information
- Founded
- VKTX 2012
- ACLX 2015
- Country
- VKTX United States
- ACLX United States
- Employees
- VKTX N/A
- ACLX N/A
- Industry
- VKTX Biotechnology: Pharmaceutical Preparations
- ACLX Biotechnology: Pharmaceutical Preparations
- Sector
- VKTX Health Care
- ACLX Health Care
- Exchange
- VKTX Nasdaq
- ACLX Nasdaq
- Market Cap
- VKTX 3.5B
- ACLX 4.1B
- IPO Year
- VKTX 2015
- ACLX 2022
- Fundamental
- Price
- VKTX $23.09
- ACLX $76.42
- Analyst Decision
- VKTX Strong Buy
- ACLX Strong Buy
- Analyst Count
- VKTX 12
- ACLX 13
- Target Price
- VKTX $87.50
- ACLX $114.75
- AVG Volume (30 Days)
- VKTX 6.8M
- ACLX 507.4K
- Earning Date
- VKTX 10-22-2025
- ACLX 11-06-2025
- Dividend Yield
- VKTX N/A
- ACLX N/A
- EPS Growth
- VKTX N/A
- ACLX N/A
- EPS
- VKTX N/A
- ACLX N/A
- Revenue
- VKTX N/A
- ACLX $56,979,000.00
- Revenue This Year
- VKTX N/A
- ACLX N/A
- Revenue Next Year
- VKTX N/A
- ACLX $174.18
- P/E Ratio
- VKTX N/A
- ACLX N/A
- Revenue Growth
- VKTX N/A
- ACLX N/A
- 52 Week Low
- VKTX $18.92
- ACLX $47.86
- 52 Week High
- VKTX $81.73
- ACLX $107.37
- Technical
- Relative Strength Index (RSI)
- VKTX 32.25
- ACLX 61.10
- Support Level
- VKTX $24.82
- ACLX $73.16
- Resistance Level
- VKTX $26.50
- ACLX $78.61
- Average True Range (ATR)
- VKTX 1.18
- ACLX 2.84
- MACD
- VKTX -0.20
- ACLX 0.55
- Stochastic Oscillator
- VKTX 2.47
- ACLX 75.42
About VKTX Viking Therapeutics Inc.
Viking Therapeutics Inc is a healthcare service provider. The company specializes in the area of biopharmaceutical development focused on metabolic and endocrine disorders. The company's clinical program pipeline consists of VK2809, VK5211, VK0214 products. VK2809 and VK0214 are orally available, tissue and receptor-subtype selective agonists of the thyroid hormone receptor beta. VK5211 is an orally available, non-steroidal selective androgen receptor modulator.
About ACLX Arcellx Inc.
Arcellx Inc a clinical-stage biotechnology company reimagining cell therapy through the development of immunotherapies for patients with cancer and other incurable diseases. Its pipeline includes Multiple Myeloma, Acute Myeloid Leukemia, Non-Oncology, and Solid Tumors.